Albert Labs receives preliminary acceptance of 35 novel clai

The company's proprietary manufacturing methodology, developed and validated in-house at Albert Labs' Vancouver facility, facilitates the production and scaling of highly potent yields of its KRN Active Pharmaceutical Ingredient.

Related Keywords

Vancouver , British Columbia , Canada , Ali Gulamhusein , Jean Saayman , Chand Jagpal , Group Albert Labs International Corp , Albert Labs International Corp , Inventive Claims , Patent Protected Technology , Albert Labs International , Albert Labs ,